Influences of postnatal age and dietary nucleotides on plasma fatty acids in the weanling rat.
Dietary nucleotides seem to play a number of physiologic roles during early life. They are improved in the maintenance of the immune system, intestinal maturation, and lipid metabolism. Nucleotides affect the conversion of essential fatty acids into their long-chain polyunsaturated (PUFA) derivatives in both preterm and at-term newborn infants. This work examines the effect of postnatal age and dietary nucleotides on the fatty acid composition of total plasma lipids and lipid fractions in the rat. Weanling rats (21 days old) were divided into three groups. The first group was killed, and the other two groups were fed a standard semipurified diet, and the same diet supplemented with 250 mg each of CMP, UMP, AMP, GMP, and IMP per 100 g of diet for 4 weeks. Advancing postnatal age led to an increase of total plasma fatty acids, especially saturated, and PUFA of the n-6 series, whereas PUFA of the n-3 series decreased. The fatty acid profile of plasma phospholipids (PL) exhibited minor changes, although there was a tendency to show lower levels of saturates and PUFA of the n-3 series and increased levels of PUFA of the n-6 series. Cholesteryl esters showed a response similar to that of PL, although the increase in arachidonic acid (20:4n-6) was significant. For triglycerides, linoleic acid (18:2n-6) and monounsaturates increased their levels, whereas saturates decreased. Dietary nucleotides mediated a significant increase in total plasma fatty acids, namely monounsaturated fatty acids and PUFA of both n-6 and n-3 series as compared with the control group. The relative fatty acid composition of PL and cholesteryl esters was mostly unaffected.(ABSTRACT TRUNCATED AT 250 WORDS)
Boza
J
J
Department of Biochemistry and Molecular Biology, University of Granada, Spain.
Jimenez
J
J
Faus
M J
MJ
Gil
A
A
D000249:Adenosine Monophosphate / Q000008:administration & dosage / Q000494:pharmacology; D000375:Aging / Q000097:blood*; D000818:Animals; D003568:Cytidine Monophosphate / Q000008:administration & dosage / Q000494:pharmacology; D004032:Diet; D005227:Fatty Acids / Q000097:blood*; D005231:Fatty Acids, Unsaturated / Q000097:blood; D006157:Guanosine Monophosphate / Q000008:administration & dosage / Q000494:pharmacology; D007291:Inosine Monophosphate / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D009711:Nucleotides / Q000008:administration & dosage / Q000494:pharmacology*; D010743:Phospholipids / Q000097:blood; D051381:Rats; D013229:Stearic Acids / Q000097:blood; D014542:Uridine Monophosphate / Q000008:administration & dosage / Q000494:pharmacology
D005227:Fatty Acids; D005231:Fatty Acids, Unsaturated; D009711:Nucleotides; D010743:Phospholipids; D013229:Stearic Acids; D007291:Inosine Monophosphate; D000249:Adenosine Monophosphate; C031183:stearic acid; D006157:Guanosine Monophosphate; D014542:Uridine Monophosphate; D003568:Cytidine Monophosphate